Listeriosis in infants: Prospective surveillance studies in Canada and Switzerland

Bahaa Abu-Raya1, Marianne Jost2, Julie A Bettinger1

  • 1Vaccine Evaluation Center, British Columbia Children's Hospital, Department of Pediatrics, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia,Canada.

Insights

Neonatal listeriosis is rare in Canada and Switzerland, with most infant cases presenting early. This suggests empiric antibiotic coverage for listeriosis in sepsis may not always be needed after the first month of life.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Listeriosis in infants is a serious concern.
  • International data is needed to inform antibiotic guidelines for infant sepsis.

Purpose of the Study:

  • Determine the incidence, clinical features, and outcomes of listeriosis in infants under six months in Canada and Switzerland.
  • Provide data to guide empiric antibiotic treatment recommendations.

Main Methods:

  • Prospective, active surveillance of listeriosis in infants <6 months.
  • Data collected via the Canadian Paediatric Surveillance Program and the Swiss Paediatric Surveillance Unit.
  • Inclusion of confirmed and probable cases.

Main Results:

  • Low incidence reported: 1.1/100,000 live births/year in Canada and 4.5/100,000 live births/year in Switzerland.
  • Most cases (66.6%) were early-onset (within 7 days of life).
  • No cases presented after 28 days of life; some Swiss cases were linked to an outbreak.

Conclusions:

  • Neonatal listeriosis is infrequent.
  • Empiric antibiotic coverage for listeriosis in infants with sepsis may not be routinely necessary after the first month of life.
  • Outbreaks can still occur, highlighting the need for ongoing surveillance.
Abstract